Need help finding what you are looking for?
Contact Us
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972956
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972956
Mitral Valve Disease Market Insights, Competitive Landscape, and Market Forecast - 2033
PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
The global Mitral Valve Disease (MVD) Market is poised for significant growth over the coming years, driven by technological advancements, rising prevalence of cardiovascular disorders, and increasing awareness of heart health. Valued at $2.9 billion in 2026, the market is projected to reach $4.8 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.2%.
Market Overview
Mitral valve disease refers to a range of heart conditions affecting the mitral valve, including mitral valve stenosis, prolapse, and regurgitation. These conditions impede the proper flow of blood through the heart, potentially causing symptoms such as shortness of breath, fatigue, and irregular heart rhythms. The increasing incidence of cardiovascular disorders, aging population, and advancements in minimally invasive surgical procedures are key factors fueling market growth.
Innovative therapies, such as transcatheter mitral valve replacement (TMVR) and cardiac resynchronization therapy (CRT), have expanded treatment options. Hospitals and specialty clinics are increasingly adopting these advanced interventions, alongside pharmacological solutions like diuretics, anticoagulants, and hypertension medications, to manage mitral valve disease effectively.
Key Market Drivers
- 1. Rising Incidence of Cardiovascular Disorders: Heart disease remains a leading global health concern. Lifestyle changes, including sedentary behavior, unhealthy diets, and obesity, have contributed to the growing prevalence of mitral valve disease.
- 2. Technological Innovations: The introduction of next-generation mitral valve repair and replacement devices has improved surgical outcomes. Minimally invasive procedures, such as TMVR, reduce patient recovery time and risk of complications, increasing adoption.
- 3. Early Diagnosis and Awareness: Advancements in diagnostic imaging, including echocardiography and cardiac MRI, enable timely detection of mitral valve abnormalities. Awareness campaigns promote early intervention, boosting demand for both surgical and therapeutic treatments.
- 4. Supportive Reimbursement Policies: Favorable insurance coverage and government initiatives for cardiac procedures enhance accessibility and affordability of treatments, further encouraging market growth.
Business Opportunities
The Mitral Valve Disease Market offers extensive opportunities for manufacturers, pharmaceutical companies, and healthcare providers. High-growth potential exists in emerging markets, particularly in Asia Pacific and Latin America, where healthcare infrastructure is expanding and awareness of cardiovascular health is rising. Collaborations between medical device companies and healthcare institutions to develop innovative, patient-centric solutions are creating additional avenues for growth.
Regional Insights
- North America leads the market due to well-established healthcare systems, high adoption of minimally invasive procedures, and ongoing investments in cardiovascular research.
- Europe follows, driven by increasing awareness, favorable reimbursement policies, and advancements in valve repair and replacement technologies.
- Asia Pacific is expected to register the fastest growth, fueled by rising prevalence of heart diseases, improving healthcare facilities, and increasing disposable income.
- Latin America and Middle East & Africa are also witnessing steady growth as healthcare infrastructure improves and access to advanced therapies expands.
Competitive Landscape
The Mitral Valve Disease Market features a combination of established global players and emerging regional innovators. Key companies operating in this sector include:
- Abbott Laboratories
- Medtronic plc
- Edwards Lifesciences Corporation
- Boston Scientific Corporation
- LivaNova PLC
- Micro Interventional Devices Inc.
- XELTIS AG
- Lepu Medical Technology (Beijing) Co. Ltd.
- CryoLife Inc.
- Colibri Heart Valve LLC
- Valcare Medical
- Affluent Medical
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Bayer AG
These companies are actively pursuing strategies such as product innovation, mergers and acquisitions, and geographic expansion to strengthen market presence and address unmet clinical needs.
Market Segmentation
By Treatment Type
- Mitral Valve Repair
- Mitral Valve Replacement
- Cardiac Resynchronization Therapy
- Mitral Valve Therapeutics
- Diuretics
- Anticoagulants
- Hypertension Drugs
By Indication
- Mitral Valve Stenosis
- Mitral Valve Prolapse
- Mitral Valve Regurgitation
By Stage
- Stage C
- Stage D
By End User
- Hospitals
- Specialty Clinics
By Geographic Coverage
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Mitral Valve Disease Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Mitral Valve Disease Market Outlook, 2020-2033
- 3.1. Global Mitral Valve Disease Market Outlook, by Treatment Type, Value (US$ Bn), 2020-2033
- 3.1.1. Mitral Valve Repair
- 3.1.1.1. Mitral Valve Replacement
- 3.1.1.2. Cardiac Resynchronization Therapy
- 3.1.2. Mitral Valve Therapeutics
- 3.1.2.1. Diuretics
- 3.1.2.2. Anticoagulants
- 3.1.2.3. Hypertension Drugs
- 3.1.1. Mitral Valve Repair
- 3.2. Global Mitral Valve Disease Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 3.2.1. Mitral Valve Stenosis
- 3.2.2. Mitral Valve Prolapse
- 3.2.3. Mitral Valve Regurgitation
- 3.3. Global Mitral Valve Disease Market Outlook, by Stage, Value (US$ Bn), 2020-2033
- 3.3.1. Stage C
- 3.3.2. Stage D
- 3.4. Global Mitral Valve Disease Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.4.1. Hospitals
- 3.4.2. Specialty Clinics
- 3.5. Global Mitral Valve Disease Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Mitral Valve Disease Market Outlook, 2020-2033
- 4.1. North America Mitral Valve Disease Market Outlook, by Treatment Type, Value (US$ Bn), 2020-2033
- 4.1.1. Mitral Valve Repair
- 4.1.1.1. Mitral Valve Replacement
- 4.1.1.2. Cardiac Resynchronization Therapy
- 4.1.2. Mitral Valve Therapeutics
- 4.1.2.1. Diuretics
- 4.1.2.2. Anticoagulants
- 4.1.2.3. Hypertension Drugs
- 4.1.1. Mitral Valve Repair
- 4.2. North America Mitral Valve Disease Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 4.2.1. Mitral Valve Stenosis
- 4.2.2. Mitral Valve Prolapse
- 4.2.3. Mitral Valve Regurgitation
- 4.3. North America Mitral Valve Disease Market Outlook, by Stage, Value (US$ Bn), 2020-2033
- 4.3.1. Stage C
- 4.3.2. Stage D
- 4.4. North America Mitral Valve Disease Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.4.1. Hospitals
- 4.4.2. Specialty Clinics
- 4.5. North America Mitral Valve Disease Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 4.5.2. U.S. Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 4.5.3. U.S. Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 4.5.4. U.S. Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 4.5.5. Canada Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 4.5.6. Canada Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 4.5.7. Canada Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 4.5.8. Canada Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Mitral Valve Disease Market Outlook, 2020-2033
- 5.1. Europe Mitral Valve Disease Market Outlook, by Treatment Type, Value (US$ Bn), 2020-2033
- 5.1.1. Mitral Valve Repair
- 5.1.1.1. Mitral Valve Replacement
- 5.1.1.2. Cardiac Resynchronization Therapy
- 5.1.2. Mitral Valve Therapeutics
- 5.1.2.1. Diuretics
- 5.1.2.2. Anticoagulants
- 5.1.2.3. Hypertension Drugs
- 5.1.1. Mitral Valve Repair
- 5.2. Europe Mitral Valve Disease Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 5.2.1. Mitral Valve Stenosis
- 5.2.2. Mitral Valve Prolapse
- 5.2.3. Mitral Valve Regurgitation
- 5.3. Europe Mitral Valve Disease Market Outlook, by Stage, Value (US$ Bn), 2020-2033
- 5.3.1. Stage C
- 5.3.2. Stage D
- 5.4. Europe Mitral Valve Disease Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.4.1. Hospitals
- 5.4.2. Specialty Clinics
- 5.5. Europe Mitral Valve Disease Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 5.5.2. Germany Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 5.5.3. Germany Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 5.5.4. Germany Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 5.5.5. Italy Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 5.5.6. Italy Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 5.5.7. Italy Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 5.5.8. Italy Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 5.5.9. France Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 5.5.10. France Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 5.5.11. France Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 5.5.12. France Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 5.5.13. U.K. Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 5.5.14. U.K. Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 5.5.15. U.K. Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 5.5.16. U.K. Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 5.5.17. Spain Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 5.5.18. Spain Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 5.5.19. Spain Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 5.5.20. Spain Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 5.5.21. Russia Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 5.5.22. Russia Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 5.5.23. Russia Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 5.5.24. Russia Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 5.5.25. Rest of Europe Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 5.5.26. Rest of Europe Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 5.5.27. Rest of Europe Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 5.5.28. Rest of Europe Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Mitral Valve Disease Market Outlook, 2020-2033
- 6.1. Asia Pacific Mitral Valve Disease Market Outlook, by Treatment Type, Value (US$ Bn), 2020-2033
- 6.1.1. Mitral Valve Repair
- 6.1.1.1. Mitral Valve Replacement
- 6.1.1.2. Cardiac Resynchronization Therapy
- 6.1.2. Mitral Valve Therapeutics
- 6.1.2.1. Diuretics
- 6.1.2.2. Anticoagulants
- 6.1.2.3. Hypertension Drugs
- 6.1.1. Mitral Valve Repair
- 6.2. Asia Pacific Mitral Valve Disease Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 6.2.1. Mitral Valve Stenosis
- 6.2.2. Mitral Valve Prolapse
- 6.2.3. Mitral Valve Regurgitation
- 6.3. Asia Pacific Mitral Valve Disease Market Outlook, by Stage, Value (US$ Bn), 2020-2033
- 6.3.1. Stage C
- 6.3.2. Stage D
- 6.4. Asia Pacific Mitral Valve Disease Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.4.1. Hospitals
- 6.4.2. Specialty Clinics
- 6.5. Asia Pacific Mitral Valve Disease Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 6.5.2. China Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 6.5.3. China Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 6.5.4. China Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 6.5.5. Japan Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 6.5.6. Japan Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 6.5.7. Japan Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 6.5.8. Japan Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 6.5.9. South Korea Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 6.5.10. South Korea Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 6.5.11. South Korea Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 6.5.12. South Korea Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 6.5.13. India Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 6.5.14. India Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 6.5.15. India Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 6.5.16. India Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 6.5.17. Southeast Asia Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 6.5.18. Southeast Asia Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 6.5.19. Southeast Asia Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 6.5.20. Southeast Asia Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 6.5.21. Rest of SAO Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 6.5.22. Rest of SAO Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 6.5.23. Rest of SAO Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 6.5.24. Rest of SAO Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Mitral Valve Disease Market Outlook, 2020-2033
- 7.1. Latin America Mitral Valve Disease Market Outlook, by Treatment Type, Value (US$ Bn), 2020-2033
- 7.1.1. Mitral Valve Repair
- 7.1.1.1. Mitral Valve Replacement
- 7.1.1.2. Cardiac Resynchronization Therapy
- 7.1.2. Mitral Valve Therapeutics
- 7.1.2.1. Diuretics
- 7.1.2.2. Anticoagulants
- 7.1.2.3. Hypertension Drugs
- 7.1.1. Mitral Valve Repair
- 7.2. Latin America Mitral Valve Disease Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 7.2.1. Mitral Valve Stenosis
- 7.2.2. Mitral Valve Prolapse
- 7.2.3. Mitral Valve Regurgitation
- 7.3. Latin America Mitral Valve Disease Market Outlook, by Stage, Value (US$ Bn), 2020-2033
- 7.3.1. Stage C
- 7.3.2. Stage D
- 7.4. Latin America Mitral Valve Disease Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.4.1. Hospitals
- 7.4.2. Specialty Clinics
- 7.5. Latin America Mitral Valve Disease Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 7.5.2. Brazil Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 7.5.3. Brazil Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 7.5.4. Brazil Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 7.5.5. Mexico Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 7.5.6. Mexico Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 7.5.7. Mexico Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 7.5.8. Mexico Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 7.5.9. Argentina Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 7.5.10. Argentina Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 7.5.11. Argentina Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 7.5.12. Argentina Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 7.5.13. Rest of LATAM Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 7.5.14. Rest of LATAM Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 7.5.15. Rest of LATAM Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 7.5.16. Rest of LATAM Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Mitral Valve Disease Market Outlook, 2020-2033
- 8.1. Middle East & Africa Mitral Valve Disease Market Outlook, by Treatment Type, Value (US$ Bn), 2020-2033
- 8.1.1. Mitral Valve Repair
- 8.1.1.1. Mitral Valve Replacement
- 8.1.1.2. Cardiac Resynchronization Therapy
- 8.1.2. Mitral Valve Therapeutics
- 8.1.2.1. Diuretics
- 8.1.2.2. Anticoagulants
- 8.1.2.3. Hypertension Drugs
- 8.1.1. Mitral Valve Repair
- 8.2. Middle East & Africa Mitral Valve Disease Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 8.2.1. Mitral Valve Stenosis
- 8.2.2. Mitral Valve Prolapse
- 8.2.3. Mitral Valve Regurgitation
- 8.3. Middle East & Africa Mitral Valve Disease Market Outlook, by Stage, Value (US$ Bn), 2020-2033
- 8.3.1. Stage C
- 8.3.2. Stage D
- 8.4. Middle East & Africa Mitral Valve Disease Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.4.1. Hospitals
- 8.4.2. Specialty Clinics
- 8.5. Middle East & Africa Mitral Valve Disease Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 8.5.2. GCC Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 8.5.3. GCC Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 8.5.4. GCC Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 8.5.5. South Africa Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 8.5.6. South Africa Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 8.5.7. South Africa Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 8.5.8. South Africa Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 8.5.9. Egypt Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 8.5.10. Egypt Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 8.5.11. Egypt Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 8.5.12. Egypt Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 8.5.13. Nigeria Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 8.5.14. Nigeria Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 8.5.15. Nigeria Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 8.5.16. Nigeria Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 8.5.17. Rest of Middle East Mitral Valve Disease Market Outlook, by Treatment Type, 2020-2033
- 8.5.18. Rest of Middle East Mitral Valve Disease Market Outlook, by Indication, 2020-2033
- 8.5.19. Rest of Middle East Mitral Valve Disease Market Outlook, by Stage, 2020-2033
- 8.5.20. Rest of Middle East Mitral Valve Disease Market Outlook, by End User, 2020-2033
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Abbott Laboratories
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Medtronic plc
- 9.4.3. Edwards Lifesciences Corporation
- 9.4.4. Boston Scientific Corporation
- 9.4.5. LivaNova PLC
- 9.4.6. Micro Interventional Devices Inc.
- 9.4.7. XELTIS AG
- 9.4.8. CryoLife Inc.
- 9.4.9. Colibri Heart Valve LLC
- 9.4.10. Valcare Medical
- 9.4.1. Abbott Laboratories
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.